1. Market Research
  2. > Pharmaceutical Market Trends

Healthcare-Acquired Infection: Devices, Pharmaceuticals, and Environmental Products

  • May 2015
  • 243 pages
  • BCC Research
Report ID: 619272

Summary

Table of Contents

This BCC Research study provides an in-depth analysis and forecast of selected areas of the global healthcare acquired infections (HAI) market. The report offers forecasts by treatment segment and type of treatment from 2015 through 2020.

Use this report to:
- Receive analysis of the global healthcare-acquired infection (HAI) market by treatment area and by type of treatment.
- Learn about the most common HAI diseases encountered by clinicians and other personnel.
- Identify the structure of the HAI market and the chief challenges and opportunities it faces.
- Learn about the key players in the HAI industry.

Highlights
- The global market for selected healthcare-acquired infection (HAI) treatments was valued at nearly $15.2 billion in 2014. This market is expected to increase from nearly $17.1 billion in 2015 to $23 billion by 2020, with a compound annual growth rate (CAGR) of 6.1% from 2015 to 2020.
- America currently holds 42% of the global market for HAI products, but that leadership position is expected to shrink to 40% by 2020.
- The asian market is expected to hold 25% of the global market for HAI products in 2015 and is expected to increase to 33% by 2020.

Introduction & Scope

INTRODUCTION

REASONS FOR DOING THE STUDY
The objective of this study is to provide an in-depth analysis and forecast of selected areas of the global healthcare-acquired infections (HAI) market. For purposes of this
report, HAI includes hospitals, nursing homes, outpatient surgery centers and dialysis centers. The focus of this report is on selected devices, pharmaceuticals and environmental products currently used or under development for treatment of viral, bacterial and fungal infections. The global market for HAI products is estimated at between $17 billion and $22 billion in 2015 (depending on the products included in the study) with mid single-digit growth through 2020. The North American market and in particular the U.S. holds the largest market share of any region at 42% to 50% and the fastest growing regions for HAI treatments are Brazil and the Asian region, particularly China and India.

STUDY GOALS AND OBJECTIVES
Healthcare-acquired infections are viral, bacterial or fungal infections that patients acquire after they are admitted to a healthcare facility. Patients can acquire these
infections from routine care; surgery; or as a complication from the use of medical devices such as ventilators, catheters and intravenous lines. This report is designed to investigate the global HAI market by treatment area and by type of treatment, with supporting tables and figures to illustrate projected growth. Within each type of treatment, regional analyses will focus on the Americas (i.e., Canada, U.S., Mexico, Central America and South America); EMRA (i.e., Europe, the Middle East, Russia and Africa); and Asia (i.e., Japan, China, India, other Western Pacific countries such as Australia and New Zealand and other Southeast Asian countries).

SCOPE AND FORMAT
This report offers forecasts by treatment segment and type of treatment, from 2015 through 2020, including supporting analyses for projections. The main market segments are analyzed by pharmaceutical treatments, environmental treatments and infection control devices/products. This report is a valuable tool for anyone assessing the HAI market and attempting to devise a strategy to successfully compete in this market. This report provides background on the structure of the HAI market and the chief challenges and opportunities it faces. It offers the information needed to understand the current market and to address the emerging one.

The report is an invaluable tool for business planners, acquisition specialists, licensing strategists, product managers, market research analysts, investing consultants and
others interested in the HAI market, its products, its participants and its future.

METHODOLOGIES AND INFORMATION SOURCES
Information for this report was obtained from a variety of primary and secondary research sources, including industry analysts, annual reports and agencies and organizations such as the U.S. Securities and Exchange Commission (SEC), the World Health Organization (WHO), the Centers for Disease Control and Prevention (CDC), the U.S. National Institutes of Health (NIH), American Hospital Association (AHA), Infectious Disease Society of America (IDSA), American Society of Heating, Refrigerating and Air Conditioning Engineers (ASHRAE), National Institute of Allergy and Infectious Diseases (NIAID), the National Hospital Discharge Survey (NHDS) and government agencies outside the U.S. Secondary sources include literature searches, journal articles, product literature and press releases. When precise information was not available, a consensus has been made using reasonable assumptions and estimates based on historical data.

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 60 Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.

Ahmad helps you find the right report:

Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

Purchase Reports From Reputable Market Research Publishers

Clinical Chemistry Reagents and Analyzers Market 2021: A 74-Country Analysis--Supplier Shares and Strategies, Volume and Sales Segment Forecasts, Technology and Instrumentation Review

  • $ 75000
  • Industry report
  • May 2017
  • by Venture Planning Group

This new 74-country report from VPGMarketResearch.com is available by region, country, market segment, section, or individual test. Please contact Client Services at reports@vpgcorp.com or +1 212 564 ...

Immunodiagnostics Analyzers and Reagents Market 2021: A 74-Country Analysis--Supplier Shares and Strategies, Volume and Sales Segment Forecasts, Technology and Instrumentation Review

  • $ 75000
  • Industry report
  • July 2017
  • by Venture Planning Group

This new 74-country survey from VPGMarketResearch.com provides a granular strategic analysis of over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein and abused drug assays performed in both ...

Cancer Diagnostics Market 2021: A 74-Country Analysis--Supplier Shares and Strategies, Emerging Tumor Markers, Volume and Sales Segment Forecasts, Technology and Instrumentation Review

  • $ 52400
  • Industry report
  • May 2017
  • by Venture Planning Group

This new 74-country report from VPGMarketResearch.com is available by region, country, market segment, section, or individual test. This report is designed to assist diagnostics industry executives, as ...


ref:plp2015

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.